Literature DB >> 1620238

Characterization of nicotinic acetylcholine receptors on cultured bovine adrenal chromaffin cells using modified L-[3H]nicotine binding assay.

K Lee1, S Miwa, K Koshimura, A Ito.   

Abstract

To characterize the properties of nicotinic acetylcholine receptors (nAChRs) in autonomic ganglia, we examined L-[3H]nicotine binding to membrane fraction prepared from cultured bovine adrenal chromaffin cells, using a modified filtration method. Binding of L-[3H]nicotine to non-treated glass fiber filters interfered with the detection of specific binding to the membrane fraction. Presoaking glass fiber filters in 3% or higher concentrations of polyethyleneimine (PEI) solution (sixty times higher than earlier used concentration) for at least 5 h could reduce the binding of L-[3H]nicotine to the filters to the background level. Specific L-[3H]nicotine binding to the membrane fraction was detected only when the membrane fraction was prepared in Ca(2+)-and Mg2+ (EDTA, EGTA and protease inhibitors were added) -free buffer. Specific binding of L-[3H]nicotine was saturable and reversible. Both computer program and Scatchard analysis revealed a single class of high affinity binding sites with an average Kd of 8.9 nM and a Bmax of 42.5 fmol/mg protein. The Hill coefficient was 0.98. In inhibition studies, both cholinergic agonists (carbachol and L-nicotine) and ganglionic agonists (lobeline and 1,1-dimethyl-4-phenylpiperazinium iodide) were much effective in inhibiting L-[3H]nicotine binding, whereas both neuromuscular blocking (alpha-bungarotoxin and d-tubocurarine) and ganglionic blocking agents were less effective. These results suggest that high affinity nicotinic binding sites on adrenal chromaffin cells are nAChRs of the ganglion-type, which have properties different from nAChRs on the neuromuscular junction but similar to nAChRs in the brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620238     DOI: 10.1007/bf00176611

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  A NEUTRAL, CALCIUM-ACTIVATED PROTEINASE FROM THE SOLUBLE FRACTION OF RAT BRAIN.

Authors:  G GUROFF
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  The pharmacological actions of polymethylene bistrimethyl-ammonium salts.

Authors:  W D M PATON; E J ZAIMIS
Journal:  Br J Pharmacol Chemother       Date:  1949-12

3.  Mapping of brain areas expressing RNA homologous to two different acetylcholine receptor alpha-subunit cDNAs.

Authors:  D Goldman; D Simmons; L W Swanson; J Patrick; S Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Primary structure and expression of beta 2: a novel subunit of neuronal nicotinic acetylcholine receptors.

Authors:  E S Deneris; J Connolly; J Boulter; E Wada; K Wada; L W Swanson; J Patrick; S Heinemann
Journal:  Neuron       Date:  1988-03       Impact factor: 17.173

5.  Evidence for a noncholinergic site for nicotine's action in brain: psychopharmacological, electrophysiological and receptor binding studies.

Authors:  L G Abood; K Lowy; A Tometsko; M MacNeil
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-02

6.  [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.

Authors:  L G Costa; S D Murphy
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

7.  [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.

Authors:  A M Martino-Barrows; K J Kellar
Journal:  Mol Pharmacol       Date:  1987-02       Impact factor: 4.436

8.  Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells.

Authors:  P Ascher; W A Large; H P Rang
Journal:  J Physiol       Date:  1979-10       Impact factor: 5.182

9.  Comparative analysis of nicotine-like receptor-ligand interactions in rodent brain homogenate.

Authors:  C Larsson; A Nordberg
Journal:  J Neurochem       Date:  1985-07       Impact factor: 5.372

10.  Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains.

Authors:  A Nordberg; A Adem; J Hardy; B Winblad
Journal:  Neurosci Lett       Date:  1988-04-12       Impact factor: 3.046

View more
  4 in total

1.  Isoflurane inhibits nicotinic acetylcholine receptor-mediated 22Na+ influx and muscarinic receptor-evoked cyclic GMP production in cultured bovine adrenal medullary cells.

Authors:  K Minami; N Yanagihara; Y Toyohira; M Tsutsui; A Shigematsu; A Wada; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

2.  Effects of hypoxia on stimulus-release coupling mechanisms in cultured bovine adrenal chromaffin cells.

Authors:  K Lee; A Sekine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

3.  Inhibition by carbamazepine of various ion channels-mediated catecholamine secretion in cultured bovine adrenal medullary cells.

Authors:  R Yoshimura; N Yanagihara; T Terao; K Minami; K Abe; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-09       Impact factor: 3.000

4.  Nicotine-Induced Effects on Nicotinic Acetylcholine Receptors (nAChRs), Ca2+ and Brain-Derived Neurotrophic Factor (BDNF) in STC-1 Cells.

Authors:  Jie Qian; Shobha K Mummalaneni; Reem M Alkahtani; Sunila Mahavadi; Karnam S Murthy; John R Grider; Vijay Lyall
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.